| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |